Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance in Patients With Primary Advanced Ovarian Cancer

This study used real-world population data to assess the trends of first-line (1L) poly(ADP-ribose) polymerase inhibitor (PARPi) maintenance treatment uptake and outcomes in patients with primary advanced ovarian cancer (AOC). METHODS: Patients diagnosed with AOC between January 1, 2017, and June 30...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, John K., Liu, Jinan, Song, Jinlin, Xiang, Cheryl, Wu, Eric, Kalilani, Linda, Hurteau, Jean A., Thaker, Premal H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles: Gynecological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281176/
https://www.ncbi.nlm.nih.gov/pubmed/37106485
http://dx.doi.org/10.1097/COC.0000000000001010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281176/
https://www.ncbi.nlm.nih.gov/pubmed/37106485
http://dx.doi.org/10.1097/COC.0000000000001010

Ejemplares similares